Caso contributivo
Bradicardia neonatale da mutazione del gene KCNQ1: revisione della letteratura della sindrome del QT lungo congenita
Neonatal Bradycardia due to mutation of the KCNQ1 gene: literature review of congenital long QT Syndrome
Ian Valencic1, Claudia Angelucci2, Gina Ancora2
1Scuola di Specializzazione in Pediatria, “Alma Mater Studiorum” Università di Bologna
2UO Terapia Intensiva Neonatale, Ospedale degli Infermi, Rimini
Settembre 2025 | DOI: 10.53126/MEBXXVIIIS170
Abstract
Congenital Long QT Syndromes (LQTS) are a heterogeneous group of channelopathies that cause an alteration in the repolarization phase, leading to a prolonged QT interval on the electrocardiogram. This condition provides the substrate for the development of malignant cardiac arrhythmias, such as bradycardia, atrioventricular block and polymorphic ventricular tachycardia with torsades de pointes. Starting from the analysis of a case involving a newborn with hemodynamically stable bradycardia on the first day of life, a literature review was conducted on the management of type 1 Long QT Syndrome, with a focus on cases involving carriers of the proband’s pathogenic variant, to identify best clinical practice actions for the diagnosis and treatment of neonatal-onset, particularly on those cases caused by the rare pathogenic variant c.1017_1019delCTT (p.Phe340del) in exon 7 of the KCNQ1 gene. Neonatal bradycardia is a nonspecific clinical sign that may be the first manifestation of Long QT Syndrome, a pathological substrate with a high risk of SIDS in the first year of life. The persistence of a prolonged QT interval (≥470 ms) after 3-4 weeks of life indicates the need to start beta-blocker therapy, even before confirmation by genetic testing. The patient’s c.1017_1019delCTT (p.Phe340del) variant, located in exon 7 of the KCNQ1 gene, which codes for the second half of the pore of the voltage-gated Kv7.1 channel, results in a haploinsufficiency effect on the membrane protein and confirms the diagnosis of familial type 1 Long QT Syndrome. Given that no arrhythmic events occurred during the lives of family members carrying the same proband mutation, even before beta-blocker therapy was initiated, one might speculate on the benign nature of the detected mutation. However, given the involvement of the transmembrane portion of the Kv7.1 voltage-gated channel, the authors strongly recommend maintaining therapy and continuing periodic cardiological follow-up.
Riassunto
Le sindromi congenite del QT lungo (Long QT Syndromes, LQTS) sono un gruppo eterogeneo di canalopatie che causano un’alterazione della fase di ripolarizzazione con allungamento del tratto QT all’elettrocardiogramma, che rappresenta il substrato per lo sviluppo di aritmie cardiache maligne quali bradicardia, blocco atrioventricolare (BAV) e tachicardie ventricolari polimorfe con torsione di punta. A partire dall’analisi di un caso di un neonato con bradicardia emodinamicamente stabile in prima giornata di vita, è stata effettuata una revisione della letteratura inerente al management della sindrome del QT lungo di tipo 1, con approfondimento della casistica dei soggetti portatori della variante patogenetica del probando, e si è cercato di individuare azioni di buona pratica clinica per la diagnosi e il trattamento di forme a esordio neonatale, in particolare determinate dalla rara variante patogenetica c.1017_1019delCTT (p.Phe340del) nell'esone 7 del gene KCNQ1. La bradicardia neonatale è un segno clinico aspecifico che può rappresentare la prima manifestazione della sindrome del QT lungo, un substrato patologico a elevato rischio di SIDS (Sudden Infant Death Syndrome) nel primo anno di vita. La persistenza di un QT allungato (≥ 470 ms) a distanza di 3-4 settimane di vita risulta essere un’indicazione all’avvio della terapia con beta-bloccante, ancor prima della conferma agli esami genetici. La variante c.1017_1019delCTT (p.Phe340del) localizzata nell'esone 7 del gene KCNQ1, codificante la seconda metà del poro del canale voltaggio-dipendente Kv7.1, determina un effetto d’aploinsufficienza della proteina di membrana e conferma la diagnosi di sindrome del QT lungo tipo 1 a trasmissione familiare. In considerazione del fatto che non si sono verificati eventi aritmici nel corso della vita dei familiari portatori della medesima mutazione del probando, anche prima dell’inizio della terapia con beta-bloccante, si potrebbe speculare sulla natura benigna della mutazione riscontrata, tuttavia, dato l’interessamento della porzione transmembrana del canale voltaggio-dipendente Kv7.1, secondo gli Autori si conferma la robusta raccomandazione al mantenimento della terapia e al proseguimento di un follow-up cardiologico periodico.
Contenuto riservato
Per leggere l'articolo è necessario effettuare il login.
Per l'acquisto del singolo articolo scrivi a
abbonamenti@medicoebambino.com
(la mail si prepara da sola con gli estremi dell'articolo);
se accedi, la richiesta parte con un click.
Parole chiave
Classificazione MeSH
Bibliografia
- Van Niekerk C, Van Deventer BS, du Toit-Prinsloo L. Long QT syndrome and sudden unex-pected infant death. J Clin Pathol 2017;70(9):808-13. DOI: 10.1136/jclinpath-2016-204199.
- Cuneo BF, Kaizer AM, Clur SA, et al; Fetal LQTS Consortium. Mothers with long QT syndrome are at increased risk for fetal death: findings from a multicenter international study. Am J Obstet Gynecol 2020;222(3):263.e1-263.e11. DOI: 10.1016/j.ajog.2019.09.004.
- Fernández-Falgueras A, Sarquella-Brugada G, Brugada J, Brugada R, Campuzano O. Cardiac Channelopathies and Sudden Death: Recent Clinical and Genetic Advances. Biology (Basel) 2017;6(1):7. DOI: 10.3390/biology6010007.
- Sarquella-Brugada G, Cesar S, Zambrano MD, et al. Electrocardiographic Assessment and Genetic Analysis in Neonates: a Current Topic of Discussion. Curr Cardiol Rev 2019;15(1):30-7. DOI: 10.2174/1573403X14666180913114806.
- Ackerman MJ, Schroeder JJ, Berry R, et al. A novel mutation in KVLQT1 is the molecular basis of inherited long QT syndrome in a near-drowning patient's family. Pediatr Res 1998;44(2):148-53. DOI: 10.1203/00006450-199808000-00002.
- Drew BJ, Ackerman MJ, Funk M, et al; American Heart Association Acute Cardiac Care Committee of the Council on Clinical Cardiology; Council on Cardiovascular Nursing; American College of Cardiology Foundation. Prevention of torsade de pointes in hospital settings: a scientific statement from the American Heart Association and the American College of Cardiology Foundation. J Am Coll Cardiol 2010;55(9):934-47. DOI: 10.1016/j.jacc.2010.01.001.
- Schwartz PJ, Stramba-Badiale M, Segantini A, et al. Prolongation of the QT interval and the sudden infant death syndrome. N Engl J Med 1998;338(24):1709-14. DOI: 10.1056/NEJM199806113382401.
- Cuneo BF. The beginnings of long QT syndrome. Curr Opin Cardiol 2015;30(1):112-7. DOI: 10.1097/HCO.0000000000000135.
- Davis AM, Glengarry J, Skinner JR. Sudden Infant Death: QT or Not QT? That Is No Longer the Question. Circ Arrhythm Electrophysiol 2016;9(6):e 003859. DOI: 10.1161/CIRCEP.115.003859.
- Lankaputhra M, Voskoboinik A. Congenital long QT syndrome: a clinician's guide. Intern Med J 2021;51(12):1999-2011. DOI: 10.1111/imj.15437.
- Ackerman MJ, Marcou CA, Tester DJ. Personalized medicine: genetic diagnosis for inherited cardiomyopathies/channelopathies. Rev Esp Cardiol (Engl Ed) 2013;66(4):298-307. DOI: 10.1016/j.rec.2012.12.010.
- Moss AJ, Shimizu W, Wilde AA, et al. Clinical aspects of type-1 long-QT syndrome by location, coding type, and biophysical function of mutations involving the KCNQ1 gene. Circulation 2007;115(19):2481-9. DOI: 10.1161/CIRCULATIONAHA.106.665406.
- Horn N, Rüb N, Wolpert C. Long- und Short-QT-Syndrome : Notfalltherapie und Sekundärprophylaxe [Long and short QT syndromes : Emergency treatment and secondary prophylaxis]. Herzschrittmacherther Elektrophysiol 2020;31(1):48-54. German. DOI: 10.1007/s00399-020-00666-y.
- Cuneo BF, Etheridge SP, Horigome H, et al. Arrhythmia phenotype during fetal life suggests long-QT syndrome genotype: risk stratification of perinatal long-QT syndrome. Circ Arrhythm Electrophysiol 2013;6(5):946-51. DOI: 10.1161/CIRCEP.113.000618.
- Anuwutnavin S, Wanitpongpan P, Chungsomprasong P, Soongswang J, Srisantiroj N, Wataganara T. Fetal long QT syndrome manifested as atrioventricular block and ventricular tachycardia: a case report and a review of the literature. Pediatr Cardiol 2013;34 (8):1955-62. DOI: 10.1007/s00246-012-0507-1.
- Baruteau AE, Perry JC, Sanatani S, Horie M, Dubin AM. Evaluation and management of bradycardia in neonates and children. Eur J Pediatr 2016;175(2):151-61. DOI: 10.1007/s00431-015-2689-z.
- Schwartz PJ, Stramba-Badiale M, Crotti L, et al. Prevalence of the congenital long-QT syndrome. Circulation 2009;120(18):1761-7. DOI: 10.1161/CIRCULATIONAHA.109.863209.
- Delogu AB, Iannotta R, Saracino A, Barone G, Romagnoli C. Long QT interval in the newborn. Early Human Development 2013; 89(4):S39-S40 DOI: 10.1016/S0378-3782(13)70092-6.
- Schwartz PJ, Ackerman MJ. The long QT syndrome: a transatlantic clinical approach to diagnosis and therapy. Eur Heart J 2013;34(40):3109-16. DOI: 10.1093/eurheartj/eht089.
- Crotti L, Celano G, Dagradi F, Schwartz PJ. Congenital long QT syndrome. Orphanet J Rare Dis 2008;3:18. DOI: 10.1186/1750-1172-3-18.
- Mazzanti A, Maragna R, Vacanti G, et al. Interplay Between Genetic Substrate, QTc Duration, and Arrhythmia Risk in Patients With Long QT Syndrome. J Am Coll Cardiol 2018;71(15):1663-71. DOI: 10.1016/j.jacc.2018.01.078.
- Pelliccia A, Fagard R, Bjørnstad HH, et al; Study Group of Sports Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology; Working Group of Myocardial and Pericardial Diseases of the European Society of Cardiology. Recommendations for competitive sports participation in athletes with cardiovascular disease: a consensus document from the Study Group of Sports Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology and the Working Group of Myocardial and Pericardial Diseases of the European Society of Cardiology. Eur Heart J 2005;26(14):1422-45. DOI: 10.1093/eurheartj/ehi325.
- Ahn J, Kim HJ, Choi JI, Lee KN, Shim J, Ahn HS, Kim YH. Effectiveness of beta-blockers depending on the genotype of congenital long-QT syndrome: A meta-analysis. PLoS One 2017;12(10):e0185 680. DOI: 10.1371/journal.pone.0185680.
- Chockalingam P, Crotti L, Girardengo G, et al. Not all beta-blockers are equal in the management of long QT syndrome types 1 and 2: higher recurrence of events under metoprolol. J Am Coll Cardiol 2012;60(20):2092-9. DOI: 10.1016/j.jacc.2012.07.046.
- Schwartz PJ, Priori SG, Cerrone M, et al. Left cardiac sympathetic denervation in the management of high-risk patients affected by the long-QT syndrome. Circulation 2004;109(15):1826-33. DOI: 10.1161/01.CIR.0000125523.14403.1E.
- Schwartz PJ, Spazzolini C, Priori SG, et al. Who are the long-QT syndrome patients who receive an implantable cardioverter-defibrillator and what happens to them?: data from the European Long-QT Syndrome Implantable Cardioverter-Defibrillator (LQTS ICD) Registry. Circulation 2010;122(13):1272-82. DOI: 10.1161/CIRCULATIONAHA.110.950147.